SCGB1A1 and COVID-19: In this case, plasma CC16 levels were significantly higher in the COVID-19 (p = 0.0147, COVID-19 vs. healthy control) and H1N1 groups (p = 0.0004, H1N1 vs. healthy control) than those in the healthy control, respectively.